Page last updated: 2024-10-29

isoniazid and Asymptomatic Conditions

isoniazid has been researched along with Asymptomatic Conditions in 1 studies

Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Danel, C	1
Moh, R	1
Gabillard, D	1
Badje, A	1
Le Carrou, J	1
Ouassa, T	1
Ouattara, E	1
Anzian, A	1
Ntakpé, JB	1
Minga, A	1
Kouame, GM	1
Bouhoussou, F	1
Emieme, A	1
Kouamé, A	2
Inwoley, A	1
Toni, TD	1
Ahiboh, H	1
Kabran, M	1
Rabe, C	1
Sidibé, B	1
Nzunetu, G	1
Konan, R	1
Gnokoro, J	1
Gouesse, P	1
Messou, E	1
Dohoun, L	1
Kamagate, S	1
Yao, A	1
Amon, S	1
Kouame, AB	1
Koua, A	1
Kouamé, E	1
Ndri, Y	1
Ba-Gomis, O	1
Daligou, M	1
Ackoundzé, S	1
Hawerlander, D	1
Ani, A	1
Dembélé, F	1
Koné, F	1
Guéhi, C	1
Kanga, C	1
Koule, S	1
Séri, J	1
Oyebi, M	1
Mbakop, N	1
Makaila, O	1
Babatunde, C	1
Babatounde, N	1
Bleoué, G	1
Tchoutedjem, M	1
Kouadio, AC	1
Sena, G	1
Yededji, SY	1
Assi, R	1
Bakayoko, A	1
Mahassadi, A	1
Attia, A	1
Oussou, A	1
Mobio, M	1
Bamba, D	1
Koman, M	1
Horo, A	1
Deschamps, N	1
Chenal, H	1
Sassan-Morokro, M	1
Konate, S	1
Aka, K	1
Aoussi, E	1
Journot, V	1
Nchot, C	1
Karcher, S	1
Chaix, ML	1
Rouzioux, C	1
Sow, PS	1
Perronne, C	1
Girard, PM	1
Menan, H	1
Bissagnene, E	1
Kadio, A	1
Ettiegne-Traore, V	1
Moh-Semdé, C	1
Massumbuko, JM	1
Chêne, G	1
Dosso, M	1
Domoua, SK	1
N'Dri-Yoman, T	1
Salamon, R	1
Eholié, SP	1
Anglaret, X	1

Clinical Trials (7)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Multicenter Clinical Trial to Evaluate the Feasibility and Outcome of Same-day Antiretroviral Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) Among Patients Testing Positive by HIV Confirmatory Tests[NCT04712058]		200 participants (Anticipated)	Interventional	2021-01-20	Recruiting
Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention: the 3HP Options Implementation Trial[NCT03934931]		1,656 participants (Actual)	Interventional	2020-07-13	Active, not recruiting
Benefits and Risks of Early Antiretroviral Therapy in HIV-infected Adults in Abidjan, Côte d'Ivoire: Randomized Controlled Trial (ANRS 12136 TEMPRANO)[NCT00495651]	Phase 3	2,073 participants (Actual)	Interventional	2008-03-31	Completed
Same Day Community-based ART Initiation Versus Clinic-based Pre-ART Assessment and Counselling for Individuals Newly Tested HIV-positive During Community-based HIV Testing in Rural Lesotho - a Randomized Controlled Trial[NCT02692027]	Phase 3	276 participants (Actual)	Interventional	2016-02-29	Completed
PROvide MIner-friendly SErvices for Integrated TB/HIV Care in Lesotho Study (PROMISE Study)[NCT03537872]		248 participants (Actual)	Interventional	2018-03-13	Completed
URBAN ARCH (3/5) Uganda Cohort TB Preventive Therapy for HIV-infected Alcohol Users in Uganda: an Evaluation of Safety Tolerability and Adherence[NCT03302299]	Phase 4	302 participants (Actual)	Interventional	2017-04-07	Completed
TB Screening Improves Preventive Therapy Uptake Trial[NCT04557176]		1,719 participants (Actual)	Interventional	2020-11-16	Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Proportion of Participants Who Accepted 3HP Treatment

The count of eligible people living with HIV (PLHIV) offered 3HP who accept to initiate treatment (by age, gender, CD4 stratum, viral load suppression) divided by the count of those randomized. (NCT03934931)
Timeframe: Within 16 weeks of treatment initiation

Intervention	proportion of participants (Number)
Facilitated Directly Observed Therapy (DOT)	0.998
Facilitated Self-Administered Therapy (SAT)	1.00
Patient Choice Between Facilitated DOT and Facilitated SAT	0.995

Proportion of Participants Who Accepted and Completed 3HP

The count of eligible participants who accept treatment and take at least 11 of 12 once weekly doses of rifapentine (RPT)/isoniazid (INH) within 16 weeks of treatment initiation divided by the count of those randomized. (NCT03934931)
Timeframe: Within 16 weeks of treatment initiation

Intervention	proportion of participants (Number)
Facilitated Directly Observed Therapy (DOT)	0.946
Facilitated Self-Administered Therapy (SAT)	0.922
Patient Choice Between Facilitated DOT and Facilitated SAT	0.944

Proportion of Participants Who Completed 3HP Treatment

Count of participants who take at least 11 of 12 doses within 16 weeks of treatment initiation divided by the count those who take at least one dose of 3HP. (NCT03934931)
Timeframe: Within 16 weeks of treatment initiation

Intervention	proportion of participants (Number)
Facilitated Directly Observed Therapy (DOT)	0.947
Facilitated Self-Administered Therapy (SAT)	0.922
Patient Choice Between Facilitated DOT and Facilitated SAT	0.949

Proportion of People Who Discontinued 3HP Treatment Due to Adverse Events/Intolerance

Count of participants for whom treatment is discontinued due to adverse events or intolerance divided by the count of those who initiated 3HP. (NCT03934931)
Timeframe: Within 16 weeks of treatment initiation

Intervention	proportion of participants (Number)
Facilitated Directly Observed Therapy (DOT)	0.0054
Facilitated Self-Administered Therapy (SAT)	0.013
Patient Choice Between Facilitated DOT and Facilitated SAT	0.0073

Cumulative Incidence of Participants Experiencing a Grade 3/4 Hepatotoxicity

Safety will be assessed by the occurrence of a Grade 3/4 hepatotoxicity at any time during the assigned treatment period. (NCT03302299)
Timeframe: Hepatotoxicity occurring during the six month course (180 pills) of isoniazid (INH), which may be taken over a maximum of 9 months.

Intervention	percent (Number)
INH and Vitamin B6	8.3

Number of Participants Who Discontinued Treatment

Lack of tolerability will be defined as any isoniazid (INH) treatment discontinuation prior to completion of the prescribed course (6 months of INH taken over a maximum period of 9 months) due to side effects or alanine transaminase (ALT)/aspartate transaminase (AST) elevations. (NCT03302299)
Timeframe: Six month course (180 pills) of isoniazid (INH), which may be taken over a maximum of 9 months.

Intervention	Participants (Count of Participants)
INH and Vitamin B6	32

Number of Participants With Alanine Transaminase (ALT) or Aspartate Transaminase (AST) Elevations at Study Screening

Alanine transaminase (ALT) or aspartate transaminase (AST) elevations (>2x the upper limit of normal) at study screening (NCT03302299)
Timeframe: Study screening visit

Intervention	Participants (Count of Participants)
Study Screening	80

Number of Participants With Latent Tuberculosis at Study Screening.

Latent tuberculosis assessed at screening via tuberculin skin testing (TST). A TST induration >=5mm was considered positive for latent tuberculosis. (NCT03302299)
Timeframe: Study screening visit

Intervention	Participants (Count of Participants)
Study Screening	308

INH Concentration in Hair: (INH Pmol + Acetyl INH Pmol) Per mg of Hair

INH concentration in hair (pmol/mg) will be measured at 3- and 6- months during INH therapy. (NCT03302299)
Timeframe: Measured at 3- and 6- months after INH initiation

Intervention	pmol/mg (Median)
	at 3 months	at 6 months
INH and Vitamin B6	36.0	37.8

Percentage of Participants With Suboptimal INH Medication Adherence

Suboptimal INH adherence was defined as <90% of days with at least 1 electronic medication management (EMM) pill cap opening in the previous 90 days, at 3- and 6-months. (NCT03302299)
Timeframe: Adherence will be measured over the 6 months on INH or until INH discontinuation (whichever is shorter)

Intervention	percentage of participants (Number)
	at 3 months	at 6 months
INH and Vitamin B6	31.3	43.9

Self-reported INH Medication Adherence: Number of Days Taking INH in the Past 30 Days

"Participants were asked In the past 30 days, how many days in total have you not taken your pill? and were presented with a visual analog scale (VAS) to indicate the percentage of INH taken in the past 30 days. We converted the VAS percentage into number of days out of 30 to match the first question. Our final self-report measure was the minimum number of the 2 self-reported measurements." (NCT03302299)
Timeframe: Self-reported INH medication adherence via VAS will be measured 3- and 6- months after starting INH

Intervention	days (Median)
	at 3 months	at 6 months
INH and Vitamin B6	30	30

Self-reported INH Medication Adherence by the Self Rating Single Item (SRSI) Scale

The Self Rating Single Item (SRSI) adherence scale asks participants to rate their ability to take their medications as prescribed over the past 30 days. Participants reporting INH use in the prior 30 days at the 3- or 6-month interview are included here, and reported their INH adherence in the prior 30 days as excellent, very good, good, fair, poor, or very poor. (NCT03302299)
Timeframe: Self-reported INH medication adherence via SRSI will be measured 3- and 6- months after starting INH

Intervention	Participants (Count of Participants)
	At 3 months72558043						At 6 months72558043
	Excellent	Very good	Good	Fair	Poor	Very poor
INH and Vitamin B6	160
INH and Vitamin B6	79
INH and Vitamin B6	38
INH and Vitamin B6	2
INH and Vitamin B6	124
INH and Vitamin B6	90
INH and Vitamin B6	41
INH and Vitamin B6	4
INH and Vitamin B6	0
INH and Vitamin B6	1

Trials

1 trial available for isoniazid and Asymptomatic Conditions

Article	Year
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. The New England journal of medicine, 2015, Aug-27, Volume: 373, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antitubercular Agents; Asympto	2015